Biriperone

This classification denotes an anxiolytic with the molecular formula C24H26FN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5776HBV7UD, chemically known as pyrazino(1,2:1,6)pyrido(3,4-b)indole, 1,2,3,4,6,7,12,12a-octahydro-2-(3-(p-fluorobenzoyl)propyl)-, dl- but generally known as biriperone, which bears US NIH Compound Identifier 68663. European Medicines Agency schedules Biriperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05845MIG. The term BIRIPERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). BIRIPERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule biriperone under HS 29335995 and SITC 51576. As of Q4 2014, BIRIPERONE remains the US FDA Preferred Term for this commodity. Biriperone bears US NLM identifiers UMLS ID C2698513 and NCI Concept Code C76438. SMILES: FC1CCC(C(=O)CCCN2CC3N(CC2)CC2[NH]C4C(C2C3)CCCC4)CC1.